Viewing Study NCT01601093


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-27 @ 7:59 AM
Study NCT ID: NCT01601093
Status: SUSPENDED
Last Update Posted: 2019-07-05
First Post: 2012-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-11
Start Date Type: None
Primary Completion Date: 2022-08-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2022-12-15
Completion Date Type: ESTIMATED
First Submit Date: 2012-04-27
First Submit QC Date: None
Study First Post Date: 2012-05-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-07-02
Last Update Post Date: 2019-07-05
Last Update Post Date Type: ACTUAL